शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

INDOUSBSEINDO US BIOTECH LTD· Agricultural Food & other ProductsLowNeutral
Announced Sat, 24 Oct, 2026 · 11:04 IST

Board to approve September 2026 quarterly and half-year results

Revenue declinedNet loss reportedEBITDA margin compressionNegative operating cash flowResults View source PDFExplain this filing

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-7.7%Reaction day
₹64.99
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-8.1% vs market
Other Agricultural Products peers, median of 55sector-0.3%-7.4% vs sector

On the reaction day the stock moved 8.1 pts less than Nifty Microcap 250 and 7.4 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-7.7+0.4-8.1-0.3-7.4
Next day
+11.4+2.1+9.2+0.6+10.7
2d
+33.6+2.2+31.4+0.3+33.3
3d
+18.5+2.9+15.6+0.1+18.4
4d
+10.8+0.3+10.5-0.1+10.9
5d
+4.2+1.8+2.4+0.3+3.8
1w
+0.2+4.2-4.1+1.9-1.8
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 55Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on 30 October 2026 to approve the company's unaudited standalone results for the quarter and six-month period ended 30 September 2026. The filing provides no financial figures or result details.

Likely market impact

The results are still pending, so their effect on earnings, cash flow and the share price cannot yet be assessed.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹15.05 Cr₹30.85 Cr−51.2%
Operating profit−₹3.70 Cr₹3.53 Cr−204.6%
Profit after tax−₹3.67 Cr₹3.45 Cr−206.4%
EBITDA margin-17.3%13.5%−30.8 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.